BAYSHORE PHARMACEUTICALS FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · May 23, 2024
  • No warning letters matched by name
Inspections 1 0 OAI
Recalls 2 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

BAYSHORE PHARMACEUTICALS has 2 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "BAYSHORE PHARMACEUTICALS" is on file.

What these totals cover: FDA records filed under the name "BAYSHORE PHARMACEUTICALS".

Latest recall
D-1544-2020 · Class II · Aug 19, 2020
Latest inspection
May 23, 2024 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls2Nov 15, 2026File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections1Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

BAYSHORE PHARMACEUTICALS's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

BAYSHORE PHARMACEUTICALS: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600000
202500000
202410000
202300000
202200000
202100000
202000020
201900000
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing BAYSHORE PHARMACEUTICALS as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check BAYSHORE PHARMACEUTICALS yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

2 recall records on Aug 19, 2020.

NumberClassProductDate
D-1544-2020Class IIMetformin Hydrochloride Extended-Release Tablets USP, 750 mg 100 Tablets Rx Only Manufactured by…Aug 19, 2020
D-1543-2020Class IIMetformin Hydrochloride Extended-Release Tablets USP, 500 mg 1000 Tablets Rx Only Manufactured by…Aug 19, 2020

Recent FDA inspections

1 inspection on May 23, 2024.

DateSiteProductClassificationFEI
May 23, 2024Tampa, FLFood/CosmeticsVoluntary Action Indicated (VAI)3009313683
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3009313683Tampa, FL1May 23, 2024

BAYSHORE PHARMACEUTICALS and the FDA: common questions

Has BAYSHORE PHARMACEUTICALS received an FDA warning letter?

No FDA warning letter addressed to the name "BAYSHORE PHARMACEUTICALS" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has BAYSHORE PHARMACEUTICALS received an FDA Form 483?

FDA has not published a Form 483 for "BAYSHORE PHARMACEUTICALS" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect BAYSHORE PHARMACEUTICALS?

The most recent FDA inspection on file ended May 23, 2024 at Tampa, FL and was classified VAI. FDA has 1 inspection of BAYSHORE PHARMACEUTICALS on file.

Has BAYSHORE PHARMACEUTICALS had an FDA recall?

Yes. BAYSHORE PHARMACEUTICALS has 2 FDA recalls on record. The most recent started Aug 19, 2020.

Need more than this page shows? Ask about BAYSHORE PHARMACEUTICALS in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.